* Applied DNA Sciences Inc is expected to show a rise in quarterly revenue when it reports results on December 12 (estimated) for the period ending September 30 2024
* The Stony Brook New York-based company is expected to report a 15.3% increase in revenue to $899 thousand from $780 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
* LSEG's mean analyst estimate for Applied DNA Sciences Inc is for a loss of 34 cents per share.
* The one available analyst rating on the shares is "hold".
* The mean earnings estimate of analysts was unchanged in the last three months.
This summary was machine generated December 10 at 21:14 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。